By doing hormone therapy up front in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results ...

Data from the PROTEUS trial showed that adding a hormone-blocking pill called apalutamide to standard hormone therapy, both ...

ADT plus apalutamide before and after surgery significantly improved metastasis-free survi ...

Johnson & Johnson’s PROTEUS Phase 3 trial shows apalutamide + hormone therapy before/after surgery improves outcomes in ...

After a prostatectomy, you’ll need to consider factors like catheter management, sexual activity, and mental health. Here’s how experts recommend approaching recovery.

In a randomized clinical trial, Mass General Brigham researchers found testosterone replacement therapy also improved quality of life for men who had undergone radical prostatectomy ...

What you need to know: 8.9% of patients on combo had little to no cancer at surgery vs 1% on hormone therapy alone. Johnson & Johnson's JNJ.N prostate cancer drug Erleada used with hormone-blocking ...

Compared with patients receiving hormone therapy alone, patients were nine times more likely to have little to no cancer remaining in the prostate after surgery, with a 20 percent reduction in the ris ...

Among men with high-risk localized prostate cancer, those receiving neoadjuvant apalutamide combination therapy had improved potency recovery by 12 months and reduced rates of positive margins ...

The addition of apalutamide to androgen deprivation therapy before and after surgery improved outcomes among men with ...

PSA test detects benign cancers which can result in men having radiotherapy, surgery or hormone therapy, putting them at risk of complications such as incontinence and impotence ...